Another study in patients affected by RCC, revealed lower ARID1A protein expression in 67% of samples and decreased ARID1A messenger RNA (mRNA) levels in 68% of samples if compared to normal kidney (74). This evidence concerns the gene ARID1A and renal cell carcinoma.